Add: issue, bibcode. | Use this bot. Report bugs. | Suggested by Smasongarrison | Linked from User:Smasongarrison/Sandbox | #UCB_webform_linked 2545/3849
→Application for medical isotope development: Removed "Which" tag: since Tc-99 is a decay product of Mo-99, and Mo-99 is created specifically to create Tc-99, there is no need to answer 'Which?'
The expected shortages{{Which|date=August 2020}} of [[Mo-99]], and the [[technetium-99m]] [[medical isotope]] obtained from it, have also shed light onto linear accelerator technology to produce Mo-99 from non-enriched [[Uranium]] through neutron bombardment. This would enable the medical isotope industry to manufacture this crucial isotope by a sub-critical process. The aging facilities, for example the [[Chalk River Laboratories]] in Ontario, Canada, which still now produce most Mo-99 from [[Enriched uranium#Highly enriched uranium (HEU)|highly enriched uranium]] could be replaced by this new process. In this way, the sub-critical loading of soluble [[Uranyl nitrate|uranium salts]] in [[heavy water]] with subsequent photo neutron bombardment and extraction of the target product, Mo-99, will be achieved.<ref>Gahl and Flagg (2009).[http://www.slideshare.net/Flagg707/subcritical-fission-mo99-production Solution Target Radioisotope Generator Technical Review]. Subcritical Fission Mo99 Production. Retrieved 6 January 2013.</ref>{{better source needed|date=August 2020}}
